KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Bristol Myers Squibb (BMY) over the last 16 years, with Q3 2025 value amounting to $406.0 million.

  • Bristol Myers Squibb's Long-Term Investments rose 2530.86% to $406.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $406.0 million, marking a year-over-year increase of 2530.86%. This contributed to the annual value of $320.0 million for FY2024, which is 1208.79% down from last year.
  • As of Q3 2025, Bristol Myers Squibb's Long-Term Investments stood at $406.0 million, which was up 2530.86% from $346.0 million recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Long-Term Investments registered a high of $406.0 million during Q3 2025, and its lowest value of $46.0 million during Q3 2021.
  • Over the past 4 years, Bristol Myers Squibb's median Long-Term Investments value was $344.0 million (recorded in 2025), while the average stood at $300.5 million.
  • As far as peak fluctuations go, Bristol Myers Squibb's Long-Term Investments crashed by 9070.71% in 2021, and later skyrocketed by 2530.86% in 2025.
  • Quarter analysis of 4 years shows Bristol Myers Squibb's Long-Term Investments stood at $46.0 million in 2021, then skyrocketed by 691.3% to $364.0 million in 2023, then decreased by 12.09% to $320.0 million in 2024, then increased by 26.88% to $406.0 million in 2025.
  • Its Long-Term Investments stands at $406.0 million for Q3 2025, versus $346.0 million for Q2 2025 and $344.0 million for Q1 2025.